Pfizer (NYSE:PFE) has opened bearishly below the pivot of $26.72 today and has reached the first level of support at $26.57. Should the shares continue to fall, the support pivots of $26.39 and $26.06 will be of interest.

Potential upside of 5.1% exists for Pfizer, based on a current level of $26.57 and analysts' average consensus price target of $27.93. The stock should discover initial support at its 50-day moving average (MA) of $25.07 and subsequent support at its 200-day MA of $23.82.

Pfizer share prices have moved between a 52-week high of $26.88 and a 52-week low of $20.75 and are now trading 28% above that low price at $26.57 per share. Over the past week, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has advanced 0.3%.

SmarTrend recommended that subscribers consider buying shares of Pfizer on December 3rd, 2012 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $25.15. Since that recommendation, shares of Pfizer have risen 6.3%. We continue to monitor PFE for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.